Asma Khan, MS, MBBS, CCRP, CCRC, is the Associate Director of Clinical Research Oversight & Quality at the Stanford Cancer Institute. She has over 15 years of clinical research experience spanning clinical trial operations, quality assurance, PRMS oversight, DSMC operations, investigator education, and regulatory compliance. Her work focuses on clinical research oversight, risk-based quality management, monitoring operations, CAPA development, inspection readiness, and implementation of operational processes aligned with FDA, NCI, and ICH-GCP expectations. Prior to transitioning into oversight and quality leadership, she worked in frontline clinical trial operations supporting both investigator-initiated and industry-sponsored studies. Ms. Khan frequently develops and delivers educational sessions on clinical research oversight, informed consent, protocol deviations, monitoring, and regulatory compliance, with a focus on practical implementation and participant protection within academic research settings.

Session:

• From Assembly Lines to Patient Visits: Why Clinical Trials Need "Factory Logic"